We are live on ! Find out more
CLPT icon

ClearPoint Neuro

39 hedge funds and large institutions have $36.1M invested in ClearPoint Neuro in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 3

361% more capital invested

Capital invested by funds: $7.84M → $36.1M (+$28.3M)

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

83% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 6

39% more funds holding

Funds holding: 2839 (+11)

6.88% more ownership

Funds ownership: 6.61%13.48% (+6.9%)

Holders
39
Holders Change
+11
Holders Change %
+39.29%
% of All Funds
0.69%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
14
Increased
11
Reduced
6
Closed
3
Calls
Puts
Net Calls
Net Calls Change

CLPT Hedge Fund Activity: Q4 2020 in Review

39 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q4 2020, worth a combined $36.1M — up 361% from $7.84M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new CLPT positions and 3 closed out — a net gain of 11 holders — while 11 added to existing stakes and 6 trimmed.

The largest buyer was Parian Global Management, opening a new position worth an estimated $4.15M. The largest seller was Merriman Wealth Management, cutting an estimated $318K.

  • 39 institutional investors held ClearPoint Neuro (CLPT) as of Q4 2020, up from 28 in Q3 2020.
  • Funds reported $36.1M of ClearPoint Neuro stock for Q4 2020, up 361% quarter-over-quarter.
  • 14 funds opened new ClearPoint Neuro positions in Q4 2020 and 3 closed out, a net change of +11 holders.
  • The largest ClearPoint Neuro buyer in Q4 2020 was Parian Global Management, an estimated $4.15M added.
  • The largest ClearPoint Neuro seller in Q4 2020 was Merriman Wealth Management, an estimated $318K sold.

Based on aggregated 13F filings for Q4 2020.